ProPhase Labs Q2 EPS $(0.22) Up From $(1.08) YoY, Sales $1.011M Down From $1.247M YoY

Benzinga Newsdesk www.benzinga.com Negative 92.1%

Neg 92.1% Neu 0% Pos 0%

ProPhase Labs (OTC:PRPH) reported quarterly losses of $(0.22) per share. This is a 79.63 percent increase over losses of $(1.08) per share from the same period last year. The company reported $1.011 million in sales this quarter. This is a 18.93 percent decrease over sales of $1.247 million the same period last year.